Check weight-loss goals and risk factors
Another trial on 1,210 people found similarly promising results, with those taking 2.4 mg of semaglutide reducing their body weight by 9.6% compared to 3.4% in the placebo group over 68 weeks of treatment
China alone has more than 100 million adults living with obesity, according to estimates from the National Health Commission of the People's Republic of China (NHC), representing one of the largest potential treatment populations globally
Who Is a Good Candidate for Each Medication
Typically, comparable medications like Tirzepatide (Zepbound) or Semaglutide (Wegovy) range from $1,000 to $1,500 monthly
Triple-action peptide structures targeting glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors represent critical study subjects in modern metabolic research